Predictive endocrine testing in the 21st century using in vitro assays of estrogen receptor signaling responses.

Thousands of environmental chemicals are subject to regulatory review for their potential to be endocrine disruptors (ED). In vitro high-throughput screening (HTS) assays have emerged as a potential tool for prioritizing chemicals for ED-related whole-animal tests. In this study, 1814 chemicals including pesticide active and inert ingredients, industrial chemicals, food additives, and pharmaceuticals were evaluated in a panel of 13 in vitro HTS assays. The panel of in vitro assays interrogated multiple end points related to estrogen receptor (ER) signaling, namely binding, agonist, antagonist, and cell growth responses. The results from the in vitro assays were used to create an ER Interaction Score. For 36 reference chemicals, an ER Interaction Score >0 showed 100% sensitivity and 87.5% specificity for classifying potential ER activity. The magnitude of the ER Interaction Score was significantly related to the potency classification of the reference chemicals (p < 0.0001). ERα/ERβ selectivity was also evaluated, but relatively few chemicals showed significant selectivity for a specific isoform. When applied to a broader set of chemicals with in vivo uterotrophic data, the ER Interaction Scores showed 91% sensitivity and 65% specificity. Overall, this study provides a novel method for combining in vitro concentration response data from multiple assays and, when applied to a large set of ER data, accurately predicted estrogenic responses and demonstrated its utility for chemical prioritization.

[1]  Ruili Huang,et al.  Using in Vitro High Throughput Screening Assays to Identify Potential Endocrine-Disrupting Chemicals , 2012, Environmental health perspectives.

[2]  M. Marino,et al.  Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: Studies on the possible mechanism of action in DU145 cells , 2007, Molecular and Cellular Endocrinology.

[3]  Rosalind,et al.  Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. , 1996, Environmental health perspectives.

[4]  John P Sumpter,et al.  Predicted‐no‐effect concentrations for the steroid estrogens estrone, 17β‐estradiol, estriol, and 17α‐ethinylestradiol , 2012, Environmental toxicology and chemistry.

[5]  G. Larsen,et al.  Atrazine is a competitive inhibitor of phosphodiesterase but does not affect the estrogen receptor. , 2004, Toxicology letters.

[6]  R. Zoeller,et al.  Evaluating the effects of endocrine disruptors on endocrine function during development. , 1999, Environmental health perspectives.

[7]  Sheng-Xiang Lin,et al.  The Contribution of 17beta-Hydroxysteroid Dehydrogenase Type 1 to the Estradiol-Estrone Ratio in Estrogen-Sensitive Breast Cancer Cells , 2012, PloS one.

[8]  E. Nelson,et al.  The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: implications for the treatment and prevention of osteoporosis. , 2013, Bone.

[9]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[10]  Vasantha Padmanabhan,et al.  Developmental programming: impact of fetal exposure to endocrine-disrupting chemicals on gonadotropin-releasing hormone and estrogen receptor mRNA in sheep hypothalamus. , 2010, Toxicology and applied pharmacology.

[11]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[12]  J. Gustafsson,et al.  Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. , 1997, Endocrinology.

[13]  Linda S Birnbaum,et al.  Cancer and developmental exposure to endocrine disruptors. , 2002, Environmental health perspectives.

[14]  A. Kolasa,et al.  Localisation of oestrogen receptors (ERalpha and ERbeta) in the human and rat epididymides. , 2003, Folia morphologica.

[15]  Robert J Kavlock,et al.  Real-time growth kinetics measuring hormone mimicry for ToxCast chemicals in T-47D human ductal carcinoma cells. , 2013, Chemical research in toxicology.

[16]  R J Kavlock,et al.  Endocrine disruptors and reproductive development: a weight-of-evidence overview. , 1997, The Journal of endocrinology.

[17]  T H Shepard,et al.  National toxicology program. , 1981, Teratology.

[18]  G. Rimbach,et al.  Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-beta in cultured human cancer cells. , 2005, The Journal of nutrition.

[19]  C. Sonnenschein,et al.  Environmental causes of cancer: endocrine disruptors as carcinogens , 2010, Nature Reviews Endocrinology.

[20]  J Ashby,et al.  The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. , 1997, Regulatory toxicology and pharmacology : RTP.

[21]  E. Jensen,et al.  Estrogen receptor (ER) , a modulator of ER in the uterus , 2000 .

[22]  Carolyn L. Smith,et al.  Molecular mechanisms of selective estrogen receptor modulator (SERM) action. , 2000, The Journal of pharmacology and experimental therapeutics.

[23]  K. Korach,et al.  Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.

[24]  J. Westendorf,et al.  Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. , 2001, Toxicology.

[25]  J. Gustafsson,et al.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.

[26]  J. Gustafsson,et al.  Estrogen receptor beta--a new dimension in estrogen mechanism of action. , 1999, The Journal of endocrinology.

[27]  Rena Li,et al.  Estrogen synthesis and signaling pathways during aging: from periphery to brain. , 2013, Trends in molecular medicine.

[28]  R. Sharpe,et al.  ERβ1 and the ERβ2 Splice Variant (ERβcx/β2) Are Expressed in Distinct Cell Populations in the Adult Human Testis , 2002 .